Partnership set to enhance CRO’s end-to-end clinical genomics services, advancing precision, collaboration, scalability, and alignment to CLIA quality standards Labbit LIMS by Semaphore Solutions set to take Eremid’s clinical genomics services to the next level in alignment with clinical quality standards. KANNAPOLIS, NC, USA – Eremid® Genomic Services, LLC (“Eremid”) announces a strategic partnership with Semaphore Solutions, a leader in informatics […]
Agreement grants rights to further develop an assay for pre-transplant prognostic testing. CARDIFF, U.K. — Verici Dx plc (AIM: VRCI), a developer of advanced clinical diagnostics for organ transplant, today announced that it has signed an exclusive global licensing agreement with Thermo Fisher Scientific, the world leader in serving science, to further develop an assay for pre-transplant […]
BRANFORD, Conn. — Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it had entered into an agreement with Elta 90 to distribute Quantum-Si’s groundbreaking Platinum™ instrument and consumables in Southeast Europe as demand grows for the first of its kind next-generation protein sequencing™ platform. This agreement between Quantum-Si and ELTA 90 holds […]
Making proteomics 100x more robust and 10x faster Today (November 15th, 2023) at the Nordic Proteomics Symposium in Lund, Sweden, Evosep, a global leader in cutting-edge proteomics solutions, is thrilled with the introduction of the revolutionary proteoCHIP™ EVO 96, a product developed in collaboration with Cellenion. Recognizing an essential demand for robust and standardized solutions […]
Early Customers Realize 10x Increase in Performance and Cloud Cost Savings; Sentieon Software Offered Free in Memory Machine Cloud Subscription MILPITAS, Calif. – MemVerge®, pioneers of Big Memory software, and Sentieon®, the market leader in genomics software, today announced a collaboration to accelerate next-generation sequencing (NGS) in the public cloud. MemVerge and Sentieon integrated the world’s most […]
OXFORD, England and BOSTON – Oxford Nanopore, the company delivering a new generation of nanopore-based molecular sensing technology, and Day Zero Diagnostics (DZD), an infectious disease diagnostics company harnessing the power of whole-genome sequencing and AI to combat the rise of antibiotic-resistant infections, today announced a collaboration to develop an end-to-end solution for the diagnosis of […]
Early Customers Realize 10x Increase in Performance and Cloud Cost Savings; Sentieon Software Offered Free in Memory Machine Cloud Subscription MILPITAS, Calif. – MemVerge®, pioneers of Big Memory software, and Sentieon®, the market leader in genomics software, today announced a collaboration to accelerate next-generation sequencing (NGS) in the public cloud. MemVerge and Sentieon integrated the […]
MATRIX’s first official research collaboration will explore the clinical value of Oxford Nanopore’s DNA and RNA sequencing technology in precision cancer medicine Oxford Nanopore Technologies plc (Oxford Nanopore) and the Norwegian Centre for Clinical Cancer Research – MATRIX – today announce a research collaboration to explore the clinical value of nanopore sequencing in precision cancer […]
New Partnership to Advance Data, Enhance Disease Detection and Care in Diverse Communities BRONX, NY — The New York Center for Rare Diseases (NYCRD) at Montefiore, recognized as a Center of Excellence by the National Organization for Rare Disorders (NORD), is partnering with GeneDx, PacBio and Google Health to deliver genetic diagnoses for Bronx families living with […]
PALO ALTO, Calif. – Bioz, Inc., a leading AI software company based in Silicon Valley, is thrilled to announce its partnership with InnovaPrep, a prominent supplier of innovative sample collection and concentration solutions that transform microbiological workflows to detect threats faster, easier, and better. InnovaPrep has been supporting industry, public health labs, academia, and government […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
